Identity
- Trade Name
- Chartis Precision Catheter FDA UDI
- Generic Name
- Bronchial balloon catheter FDA UDI
- Device Name
- The Chartis Precision Catheter is a single use, sterile, disposable device designed to be inserted into the working channel of a standard video or fiber bronchoscope during a diagnostic bronchoscopy procedure. After the target lung segment is accessed by the bronchoscope, the distal tip of the Chartis Precision Catheter can be introduced through the bronchoscope directly into the target airway. Inflation of the compliant balloon on the distal tip of the Chartis Precision Catheter causes the airway to become sealed and isolated. Air can then flow out of the isolated lung compartment into the environment only through the central lumen of the Chartis Precision Catheter. Assessment is accomplished by measuring air flows and pressures exiting the Chartis Precision Catheter lumen during spontaneous respiration or air flow during mechanical ventilation. The Chartis Precision Catheter is designed for use in conjunction with the Chartis Console. FDA UDI
- Model / Reference
- G4 FDA UDI
- Description
- The Chartis Precision Catheter is a single use, sterile, disposable device designed to be inserted into the working channel of a standard video or fiber bronchoscope during a diagnostic bronchoscopy procedure. After the target lung segment is accessed by the bronchoscope, the distal tip of the Chartis Precision Catheter can be introduced through the bronchoscope directly into the target airway. Inflation of the compliant balloon on the distal tip of the Chartis Precision Catheter causes the airway to become sealed and isolated. Air can then flow out of the isolated lung compartment into the environment only through the central lumen of the Chartis Precision Catheter. Assessment is accomplished by measuring air flows and pressures exiting the Chartis Precision Catheter lumen during spontaneous respiration or air flow during mechanical ventilation. The Chartis Precision Catheter is designed for use in conjunction with the Chartis Console. FDA UDI
Identifiers
- Catalog Number
- CHR-CA-15.0 FDA UDI
- Primary DI / UDI-DI
- 00811907031925 FDA UDI
- FDA Product Code
- CBI FDA UDI
- GMDN Term
- Bronchial balloon catheter FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 868.5740 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
MR Unsafe FDA UDI
Dimensions & Sizes
- Size
- Catheter Working Length — 72 Centimeter FDA UDIBalloon Diameter — 13 Millimeter FDA UDILength — 145 Centimeter FDA UDI
Category: Bronchial balloon catheter
Chartis Precision Catheter by Pulmonx Corporation — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Bronchial balloon catheter.
- MultiStage® — Dongguan TT Medical, Inc. · Class II
- Elation™ — Merit Medical Systems, Inc. · Class II
- INSPIRA AIR — ACCLARENT, INC. · Class II
- Elation™ — Merit Medical Systems, Inc. · Class II
- MultiStage® — Dongguan TT Medical, Inc. · Class II
- UNIBLOCKER — Fuji Systems Corp. · Class II
- INSPIRA AIR — ACCLARENT, INC. · Class II
- Blowfish Micro-Infusion Catheter — Mercator MedSystems, Inc. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Pulmonx Corporation
Sources (1)
- FDA UDI 96d992c2-6acc-4411-8097-e1901768cfa7 37 fields · synced Jun 8, 2026